Published in N Engl J Med on February 11, 1971
Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75. J Nucl Med (2000) 2.17
201Tl as a tumour-localizing agent: current status and future considerations. Nucl Med Commun (1993) 1.43
Imaging of bone metastases with 99m Tc-Sn-EHDP (diphosphonate), 18 F, and skeletal radiography. A comparison of sensitivity. Radiology (1973) 1.30
Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide. J Nucl Med (2001) 1.25
Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells. J Clin Invest (1998) 1.14
Fibrosing mediastinitis causing nonvisualization of one lung on pulmonary scintigraphy. Clin Nucl Med (1993) 1.13
Successful storage of RBCs for 10 weeks in a new additive solution. Transfusion (2000) 1.10
A "do it yourself" family care program. Ohio State Med J (1971) 1.06
Kinetics of endothelial cell seeding. J Vasc Surg (1985) 1.06
Buffering and dilution in red blood cell storage. Transfusion (2006) 0.97
Procedure guideline for gallium scintigraphy in the evaluation of malignant disease. Society of Nuclear Medicine. J Nucl Med (1997) 0.96
Radiobiological evaluation of immigrants from the vicinity of Chernobyl. Int J Radiat Biol (1997) 0.94
Bone scintigraphy screening in stage I-II breast cancer: is it cost-effective? Cleve Clin J Med (1996) 0.90
Reverse redistribution phenomenon in thallium-201 stress tests: angiographic correlation and clinical significance. J Nucl Med (1985) 0.89
Isolated right superior vena cava draining into left atrium diagnosed by radionuclide angiocardiography. J Nucl Med (1973) 0.86
67Ga as a diagnostic agent for the detection of head and neck tumors and lymphoma. Radiology (1974) 0.86
A case of elevated spontaneous micronucleus frequency derived from chromosome 2. Mutat Res (1999) 0.85
Strontium-89 therapy for the pain of osseous metastases. J Nucl Med (1985) 0.85
Increased gut blood flow with early enteral feeding in burned guinea pigs. J Burn Care Rehabil (1989) 0.85
The effect of fibronectin coating on endothelial cell kinetics in polytetrafluoroethylene grafts. J Vasc Surg (1986) 0.85
Tc-99m diphosphonate and sulfur colloid uptake by the spleen in sickle disease: interrelationship and clinical correlates: concise communication. J Nucl Med (1984) 0.84
Thrombogenicity of a fibronectin-coated, experimental polytetrafluoroethylene graft. Surgery (1987) 0.84
Clinical significance of serum vitamin B12 measured by radioassay using pure intrinsic factor. J Nucl Med (1981) 0.84
Radionuclide imaging. Use in diagnosis of osteomyelitis in children. JAMA (1977) 0.83
Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments. J Nucl Med (1993) 0.83
Treatment of polycythemia vera with hydroxyurea. Am J Hematol (1984) 0.83
Idiopathic pulmonary ossification with focal pulmonary uptake of technetium-99m HMDP bone scanning agent. Clin Nucl Med (1985) 0.83
The value of hepatobiliary scans in fasted patients receiving total parenteral nutrition. Surgery (1987) 0.82
An evaluation of undergraduate family care programs. J Community Health (1978) 0.82
Successful storage of RBCs for 9 weeks in a new additive solution. Transfusion (2000) 0.81
Semiautomated system for simultaneous assays of serum vitamin B12 and folic acid in serum evaluated. Clin Chem (1982) 0.81
Causes of abnormalities reported in nuclear medicine testing. J Nucl Med (1976) 0.80
Whole body and partial body radiotherapy of advanced cancer. Am J Roentgenol Radium Ther Nucl Med (1973) 0.80
A pathophysiologic study of the hypertension associated with burn injury in children. Ann Surg (1981) 0.80
Calculating lens dose and surface dose rates from 90Sr ophthalmic applicators using Monte Carlo modeling. Med Phys (1998) 0.80
Radon update: facts concerning environmental radon: levels, mitigation strategies, dosimetry, effects and guidelines. SNM Committee on Radiobiological Effects of Ionizing Radiation. J Nucl Med (1994) 0.79
Visualization of alcohol-induced rhabdomyolysis: a correlative radiotracer, histochemical, and electron-microscopic study. J Nucl Med (1979) 0.79
Cancer diagnosis. The role of tumor-imaging radiopharmaceuticals. Am J Med (1976) 0.78
Dosage and response in radiopharmaceutical therapy of painful osseous metastases. J Nucl Med (1996) 0.78
A quantitative method to measure human platelet chemotaxis using indium-111-oxine-labeled gel-filtered platelets. Blood (1982) 0.78
Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study. Clin Cancer Res (1998) 0.78
Synthesis and renal excretion of technetium-99m-labeled organic cations. J Nucl Med (1992) 0.78
Early burn wound excision and skin grafting postburn trauma restores in vivo neutrophil delivery to inflammatory lesions. Arch Surg (1988) 0.78
Fibronectin coating of an experimental PTFE vascular prosthesis. J Surg Res (1986) 0.78
Studies in red blood cell preservation. 7. In vivo and in vitro studies with a modified phosphate-ammonium additive solution. Vox Sang (1993) 0.76
Clinical comparison of technetium-99m diphosphonate and pyrophosphate in bone scintigraphy: concise communication. J Nucl Med (1978) 0.76
The potential unreliability of indium 111 oxine labeling in studies of endothelial cell kinetics. J Vasc Surg (1989) 0.76
RBC storage for 11 weeks. Transfusion (2001) 0.76
In vivo chemotaxis and body compartment distribution of indium-111 labelled polymorphonuclear leukocytes in burned guinea pigs. J Trauma (1983) 0.76
Preclinical evaluation of radiopharmaceutical toxicology prerequisites. Nucl Med Biol (2000) 0.75
Myasthenia gravis, haemolytic anaemia, and lymphoreticular malignancy. Br Med J (1970) 0.75
Radionuclide therapy of hematologic disorders. Semin Nucl Med (1979) 0.75
The treatment of painful osteoblastic metastases: what can we expect from nuclear oncology? J Nucl Med (1994) 0.75
Radioactivity variations in cobalt-57 cyanocobalamin capsules. J Nucl Med (1990) 0.75
The human lymphocyte as a radiobiological dosimeter after total body irradiation. Radiat Res (1974) 0.75
How to be an effective risk communicator--Part 1. J Nucl Med (1996) 0.75
Adverse reactions to radiopharmaceuticals: the SNM/RSNA USP Drug Product Problem Reporting Program. Society of Nuclear Medicine/Radiological Society of North America. United States Pharmacopeial Convention. J Nucl Med (1997) 0.75
Lung scintigraphy. Chest (1987) 0.75
Value of 48- or 72-hr urine collections in performing the Schilling test. J Nucl Med (1973) 0.75
Venous uptake of 201T1 as thallous chloride. Nucl Med Commun (1984) 0.75
The effect of the thromboxane synthetase inhibitor Dazmegrel (UK-38,485) on wound healing, dermal ink perfusion and skin blood flow measurements in deep partial thickness burns. Burns Incl Therm Inj (1986) 0.75
111-In-bleomycin kinetics in mice bearing transplantable tumors of lung, skin, and bone. J Nucl Med (1974) 0.75
How to be an effective risk communicator. J Nucl Med (1996) 0.75
Distribution of 99mTc-Sn diphosphonate and free 99mTc-pertechnetate in selected soft and hard tissues. J Nucl Med (1975) 0.75
Letter: Extension of two-part consent form. N Engl J Med (1974) 0.75
Brain scintigraphy in the diagnosis of the sequelae of head trauma. Semin Nucl Med (1983) 0.75
Anorectal bleeding vs penile activity. A potential diagnostic problem. Clin Nucl Med (1984) 0.75
Sensitivity test of perfusion lung images: lateral views vs oblique views. Int J Nucl Med Biol (1976) 0.75
Femoral artery calcification. Detection by bone scintigraphy. Clin Nucl Med (1985) 0.75
Optimizing brain-scan sensitivity. J Nucl Med (1978) 0.75
Bacterial infectibility of chronically implanted endothelial cell-seeded expanded polytetrafluoroethylene vascular grafts. J Vasc Surg (1988) 0.75
Gallium-67 in primary lung carcinoma. J Nucl Med (1978) 0.75
A comparison between fibronectin and Matrigel pretreated ePTFE vascular grafts. Ann Vasc Surg (1989) 0.75
Bone scintigraph minification without equipment modification. Int J Nucl Med Biol (1976) 0.75
Detection of clinically occult axillary metastases from breast cancer during stress TI-201 scintigraphy. Clin Nucl Med (1991) 0.75
Unreported side effect of sincalide. Radiology (1994) 0.75
Implications of "unco-operative". N Engl J Med (1970) 0.75
Laminectomy: effects on postoperative technetium and gallium scintigraphy. Radiology (1984) 0.75
Liver and brain scans. JAMA (1977) 0.75
Thermographically measured normal skin temperature asymmetry in the human male. Cancer (1975) 0.75
Indium 111 toxicity in the human lymphocyte. J Lab Clin Med (1985) 0.75
Physiologic and biologic behavior of autologous canine 131L-fibrinogen labeled by a chloramine-T method. J Lab Clin Med (1977) 0.75
The relationship of information density to pre-set counts obtained in brain, lung and liver scintigraphy. Radiology (1979) 0.75
The importance of the lateral view in Ga-67 citrate imaging of the thorax. Esophageal carcinoma. Clin Nucl Med (1982) 0.75
Assay of 32P-sodium phosphate. J Nucl Med (1977) 0.75
Letter: Neutrophilic leukemia. Ann Intern Med (1974) 0.75
Epidural hematoma with decreased radionuclide uptake. J Nucl Med (1974) 0.75
The determination of optimum glycine concentration for the perparation of human fibrinogen at ambient temperatures. Thromb Diath Haemorrh (1973) 0.75
Predictive value of intracutaneous xenon clearance for healing of amputation and cutaneous ulcer sites. Radiology (1983) 0.75
Motion-corrected hepatic scintigraphy. J Nucl Med (1978) 0.75
Radionuclide imaging of Meckel's diverticulum in children. Clin Nucl Med (1978) 0.75
Incidental detection of obstructive uropathy during scrotal imaging. Clin Nucl Med (1988) 0.75
Perfusion and ventilation scans in patients with extensive obstructive airway disease: utility of single-breath (washin) xenon-133. J Nucl Med (1995) 0.75
The Schilling test. JAMA (1969) 0.75
Diagnosis of metastatic liver cancer. JAMA (1983) 0.75
Scintiscanning with gallium citrate 67. Diagnosis of head and neck malignant neoplasms. Arch Otolaryngol (1974) 0.75
Still more applications of hepatobiliary scintigraphy. J Nucl Med (1980) 0.75
Red blood cell membrane microviscosity correlates with posttransfusion survival. Biochem Biophys Res Commun (1988) 0.75
Letter: Calcium, phosphorus, 99mTc "uptake". J Nucl Med (1974) 0.75
Incidental finding of crossed renal ectopia diagnosed on bone scan. Clin Nucl Med (1991) 0.75